PBE

#7449
Invesco Biotechnology & Genome ETF
81.18 USD
+2.56%
Setor: Finanças
Base: USD
Moeda do lucro: USD
Faixa diária
81.18
81.18
Faixa anual
58.15
85.71
Mudança diária
+2.56%
Mudança mensal
+4.88%
Mudança em 6 meses
+14.15%
Mudança anual
+35.46%
Fechamento anterior
79.15
Abrir
81.18
Bid
Ask
Mínimo
81.18
High
81.18
Volume
1
Abrir gráfico completo
Principais ativos Market Value Shares Weight %
 Invesco Private Prime Fund 17.96 M 17.96 M 7.67%
ILMN Illumina, Inc. 13.36 M 108.18 K 5.71% BIIB Biogen Inc. 12.05 M 78.12 K 5.15% INCY Incyte Corp. 11.89 M 127.15 K 5.08% REGN Regeneron Pharmaceuticals, Inc. 11.85 M 18.18 K 5.06% GILD Gilead Sciences, Inc. 11.15 M 93.08 K 4.76%
 Royalty Pharma PLC 11.14 M 296.86 K 4.76%
AMGN Amgen Inc. 11.01 M 36.88 K 4.70% IONS Ionis Pharmaceuticals, Inc. 10.26 M 138.16 K 4.38% UTHR United Therapeutics Corp. 8.39 M 18.84 K 3.58% PTCT PTC Therapeutics, Inc. 8.05 M 117.79 K 3.44% MNKD MannKind Corp. 8.00 M 1.43 M 3.42% VCYT Veracyte, Inc. 7.23 M 200.41 K 3.09%
 Invesco Private Government Fund 6.90 M 6.90 M 2.95%
TECH Bio-Techne Corp. 6.42 M 102.59 K 2.74% CPRX Catalyst Pharmaceuticals, Inc. 6.21 M 292.17 K 2.65% NBIX Neurocrine Biosciences, Inc. 6.10 M 42.58 K 2.60% EXEL Exelixis, Inc. 5.88 M 151.96 K 2.51% MDGL Madrigal Pharmaceuticals, Inc. 5.74 M 13.71 K 2.45% VCEL Vericel Corp. 5.60 M 159.83 K 2.39%

Notícias